Retractable Technologies, Inc. (NYSEMKT:RVP) was upgraded by research analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Monday.

Shares of Retractable Technologies (NYSEMKT RVP) opened at 0.591 on Monday. The company’s 50 day moving average is $0.68 and its 200 day moving average is $1.02. The company’s market capitalization is $18.71 million. Retractable Technologies has a 12-month low of $0.54 and a 12-month high of $2.74.

Retractable Technologies (NYSEMKT:RVP) last posted its quarterly earnings results on Monday, August 14th. The company reported ($0.05) earnings per share for the quarter. Retractable Technologies had a negative net margin of 17.65% and a negative return on equity of 22.24%. The company had revenue of $7.65 million during the quarter. Analysts expect that Retractable Technologies will post ($0.46) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Retractable Technologies, Inc. (RVP) Stock Rating Upgraded by ValuEngine” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at

In other news, insider Thomas J. Shaw purchased 1,000,000 shares of the company’s stock in a transaction on Wednesday, August 23rd. The shares were purchased at an average cost of $0.57 per share, with a total value of $570,000.00. Following the completion of the transaction, the insider now owns 13,065,642 shares of the company’s stock, valued at approximately $7,447,415.94. The transaction was disclosed in a filing with the SEC, which is available through this link.

An institutional investor recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC boosted its holdings in shares of Retractable Technologies, Inc. (NYSEMKT:RVP) by 6.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 583,062 shares of the company’s stock after buying an additional 36,898 shares during the quarter. WealthTrust Axiom LLC owned approximately 1.84% of Retractable Technologies worth $740,000 at the end of the most recent reporting period.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe.

Receive News & Ratings for Retractable Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.